Literature DB >> 34076574

Modelling tool to support decision-making in the NHS Health Check programme: workshops, systematic review and co-production with users.

Martin O'Flaherty1, Ffion Lloyd-Williams1, Simon Capewell1, Angela Boland2, Michelle Maden2, Brendan Collins1, Piotr Bandosz1, Lirije Hyseni1, Chris Kypridemos1.   

Abstract

BACKGROUND: Local authorities in England commission the NHS Health Check programme to invite everyone aged 40-74 years without pre-existing conditions for risk assessment and eventual intervention, if needed. However, the programme's effectiveness, cost-effectiveness and equity impact remain uncertain. AIM: To develop a validated open-access flexible web-based model that enables local commissioners to quantify the cost-effectiveness and potential for equitable population health gain of the NHS Health Check programme.
OBJECTIVES: The objectives were as follows: (1) co-produce with stakeholders the desirable features of the user-friendly model; (2) update the evidence base to support model and scenario development; (3) further develop our computational model to allow for developments and changes to the NHS Health Check programme and the diseases it addresses; (4) assess the effectiveness, cost-effectiveness and equity of alternative strategies for implementation to illustrate the use of the tool; and (5) propose a sustainability and implementation plan to deploy our user-friendly computational model at the local level.
DESIGN: Co-production workshops surveying the best-performing local authorities and a systematic literature review of strategies to increase uptake of screening programmes informed model use and development. We then co-produced the workHORSE (working Health Outcomes Research Simulation Environment) model to estimate the health, economic and equity impact of different NHS Health Check programme implementations, using illustrative-use cases.
SETTING: Local authorities in England. PARTICIPANTS: Stakeholders from local authorities, Public Health England, the NHS, the British Heart Foundation, academia and other organisations participated in the workshops. For the local authorities survey, we invited 16 of the best-performing local authorities in England.
INTERVENTIONS: The user interface allows users to vary key parameters that represent programme activities (i.e. invitation, uptake, prescriptions and referrals). Scenarios can be compared with each other. MAIN OUTCOME MEASURES: Disease cases and case-years prevented or postponed, incremental cost-effectiveness ratios, net monetary benefit and change in slope index of inequality.
RESULTS: The survey of best-performing local authorities revealed a diversity of effective approaches to maximise the coverage and uptake of NHS Health Check programme, with no distinct 'best buy'. The umbrella literature review identified a range of effective single interventions. However, these generally need to be combined to maximally improve uptake and health gains. A validated dynamic, stochastic microsimulation model, built on robust epidemiology, enabled service options analysis. Analyses of three contrasting illustrative cases estimated the health, economic and equity impact of optimising the Health Checks, and the added value of obtaining detailed local data. Optimising the programme in Liverpool can become cost-effective and equitable, but simply changing the invitation method will require other programme changes to improve its performance. Detailed data inputs can benefit local analysis. LIMITATIONS: Although the approach is extremely flexible, it is complex and requires substantial amounts of data, alongside expertise to both maintain and run.
CONCLUSIONS: Our project showed that the workHORSE model could be used to estimate the health, economic and equity impact comprehensively at local authority level. It has the potential for further development as a commissioning tool and to stimulate broader discussions on the role of these tools in real-world decision-making. FUTURE WORK: Future work should focus on improving user interactions with the model, modelling simulation standards, and adapting workHORSE for evaluation, design and implementation support. STUDY REGISTRATION: This study is registered as PROSPERO CRD42019132087. FUNDING: This project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment programme and will be published in full in Health Technology Assessment; Vol. 25, No. 35. See the NIHR Journals Library website for further project information.

Entities:  

Keywords:  CARDIOVASCULAR DISEASE; CO-PRODUCTION; COST-EFFECTIVENESS; ECONOMICS; EFFECTIVENESS; EQUITY; GROUP MODEL BUILDING; LOCAL AUTHORITIES; MICROSIMULATION MODELLING; NHS HEALTH CHECK PROGRAMME; POPULATION HEALTH GAIN; STAKEHOLDER ENGAGEMENT; UMBRELLA REVIEW

Mesh:

Year:  2021        PMID: 34076574      PMCID: PMC8201571          DOI: 10.3310/hta25350

Source DB:  PubMed          Journal:  Health Technol Assess        ISSN: 1366-5278            Impact factor:   4.014


  170 in total

1.  Are community-based health worker interventions an effective approach for early diagnosis of cancer? A systematic review and meta-analysis.

Authors:  Sarah Bellhouse; Lorna McWilliams; Joseph Firth; Janelle Yorke; David P French
Journal:  Psychooncology       Date:  2017-11-23       Impact factor: 3.894

2.  Rapid mortality falls after risk-factor changes in populations.

Authors:  Simon Capewell; Martin O'Flaherty
Journal:  Lancet       Date:  2011-03-15       Impact factor: 79.321

3.  Model parameter estimation and uncertainty: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--6.

Authors:  Andrew H Briggs; Milton C Weinstein; Elisabeth A L Fenwick; Jonathan Karnon; Mark J Sculpher; A David Paltiel
Journal:  Value Health       Date:  2012 Sep-Oct       Impact factor: 5.725

Review 4.  Cervical cancer screening interventions for U.S. Latinas: a systematic review.

Authors:  Jacqueline Corcoran; Patrick Dattalo; Meghan Crowley
Journal:  Health Soc Work       Date:  2012-11

5.  Evaluation of Interventions Intended to Increase Colorectal Cancer Screening Rates in the United States: A Systematic Review and Meta-analysis.

Authors:  Michael K Dougherty; Alison T Brenner; Seth D Crockett; Shivani Gupta; Stephanie B Wheeler; Manny Coker-Schwimmer; Laura Cubillos; Teri Malo; Daniel S Reuland
Journal:  JAMA Intern Med       Date:  2018-12-01       Impact factor: 21.873

6.  Prostate Cancer Screening Patient Decision Aids: A Systematic Review and Meta-analysis.

Authors:  Ilya Ivlev; Silvie Jerabkova; Meenakshi Mishra; Lily A Cook; Karen B Eden
Journal:  Am J Prev Med       Date:  2018-10-16       Impact factor: 5.043

Review 7.  Are cardiovascular disease risk assessment and management programmes cost effective? A systematic review of the evidence.

Authors:  John Tayu Lee; Kenny D Lawson; Yizhou Wan; Azeem Majeed; Stephen Morris; Michael Soljak; Christopher Millett
Journal:  Prev Med       Date:  2017-01-11       Impact factor: 4.018

8.  UK stroke incidence, mortality and cardiovascular risk management 1999-2008: time-trend analysis from the General Practice Research Database.

Authors:  Sally Lee; Anna C E Shafe; Martin R Cowie
Journal:  BMJ Open       Date:  2011-01-01       Impact factor: 2.692

9.  Effect of screening and lifestyle counselling on incidence of ischaemic heart disease in general population: Inter99 randomised trial.

Authors:  Torben Jørgensen; Rikke Kart Jacobsen; Ulla Toft; Mette Aadahl; Charlotte Glümer; Charlotta Pisinger
Journal:  BMJ       Date:  2014-06-09

10.  The NHS Health Check in England: an evaluation of the first 4 years.

Authors:  John Robson; Isabel Dostal; Aziz Sheikh; Sandra Eldridge; Vichithranie Madurasinghe; Chris Griffiths; Carol Coupland; Julia Hippisley-Cox
Journal:  BMJ Open       Date:  2016-01-13       Impact factor: 2.692

View more
  1 in total

1.  What factors influence differential uptake of NHS Health Checks, diabetes and hypertension reviews among women in ethnically diverse South London? Cross-sectional analysis of 63,000 primary care records.

Authors:  Mariam Molokhia; Dr Salma Ayis; Alexis Karamanos; Dr Veline L'Esperance; Sarah Yousif; Stevo Durbaba; Vasa Ćurčin; Mark Ashworth; Seeromanie Harding
Journal:  EClinicalMedicine       Date:  2022-05-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.